Drug Discovery and Drug Screening
The process through which drugs are found and/or developed in pharmacology, biotechnology, and medicine is known as drug discovery. The steps in the drug development process include the identification of candidates, synthesis, characterization, screening, and testing of therapeutic efficacy. In the past, drugs were discovered accidentally, like penicillin, or by extracting the active ingredient from therapies that were already in use. To check for the presence of chemicals and contaminants that drugs may have left in the body, drug testing involves collecting and analysing samples of blood, urine, hair, or saliva.
Related Conference of Drug Discovery and Drug Screening
April 26-27, 2027
30th International Conference on Neuropharmacology and Neurochemistry
Amsterdam, Netherlands
July 12-13, 2027
5th International Forum on Pharmacovigilance and Regulatory Affairs
Toronto, Canada
Drug Discovery and Drug Screening Conference Speakers
Recommended Sessions
- Pharmacology
- Adverse drug reactions
- Autonomic Pharmacology
- Cardiovascular Pharmacology
- Clinical Pharmacology
- Drug Discovery and Drug Screening
- Environmental Pharmacology
- Ethnopharmacology
- Forensic Toxicology
- Genetic Toxicology
- Neuropharmacology
- Nursing Pharmacology
- Pharmaceutical Chemistry
- Pharmacodynamics
- Pharmacokinetics
- Pharmacological Testing
- Psychopharmacology
- Toxicology
Related Journals
Are you interested in
- Artificial Intelligence in Neuropharmacological Drug Discovery - Neuropharmaceutics 2027 (Netherlands)
- Blood-Brain Barrier Pharmacology and Drug Delivery - Neuropharmaceutics 2027 (Netherlands)
- Brain-Computer Interfaces and Neurochemical Modulation - Neuropharmaceutics 2027 (Netherlands)
- Computational and Systems Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Digital Biomarkers and Neurochemical Monitoring Technologies - Neuropharmaceutics 2027 (Netherlands)
- Integrating Neurochemistry with Computational Brain Modeling - Neuropharmaceutics 2027 (Netherlands)
- Machine Learning Models in Neurochemical Data Analysis - Neuropharmaceutics 2027 (Netherlands)
- Molecular Mechanisms in Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Basis of Epilepsy and Anticonvulsant Pharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Basis of Mood Disorders and Emotional Regulation - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Big Data and Cloud-Based Pharmacology Platforms - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Biosensors and Real-Time Brain Monitoring - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Mechanisms in Neurodegenerative Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Signaling and Synaptic Transmission - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Addiction and Reward Pathways - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Neuroendocrine Regulation - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Psychiatric and Mood Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuroimaging Analytics and Computational Mapping of Brain Chemistry - Neuropharmaceutics 2027 (Netherlands)
- Neuroinflammation and Pharmacological Modulation - Neuropharmaceutics 2027 (Netherlands)
- Neuroinformatics and Computational Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacological Approaches to Pain and Analgesia - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacological Approaches to Pain Modulation and Analgesia - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Addiction and Substance Abuse - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Cognitive Function and Memory - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neurodegenerative Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neurodevelopmental and Autism Spectrum Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neuroplasticity and Neural Regeneration - Neuropharmaceutics 2027 (Netherlands)
- Neurotransmitter Receptors and Signal Transduction - Neuropharmaceutics 2027 (Netherlands)
- Precision Neuropharmacology through Artificial Intelligence and Genomic Profiling - Neuropharmaceutics 2027 (Netherlands)
- Virtual Drug Screening and Molecular Docking in Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
